Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimensMarie Sebert,Lucie Freiman,Cendrine Chaffaut,Agnes Guerci,Pierre Peterlin,Sylvain Thepot,Odile Beyne-Rauzy,Sophie Park,Thomas Cluzeau,Fatiha Chermat,Pierre Fenaux,Claude Preudhomme,Emmanuelle Clappier,Sylvie Chevret,Lionel Ades,Nicolas Duployez,Matthieu DuchmannLEUKEMIA（2024）引用 0|浏览24暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
